Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer
ClinicalTrials.gov study NCT04838899. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT06305598. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT05766371. IPD Sharing: NO. Countries: 1. Publications: 0.
Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer
ClinicalTrials.gov study NCT04653740. IPD Sharing: YES. Countries: 1. Publications: 0.
Organoids Predict Therapeutic Response in Patients With Multi-line Drug-resistant Lung Cancer
ClinicalTrials.gov study NCT05669586. IPD Sharing: NO. Countries: 1. Publications: 0.
Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer
ClinicalTrials.gov study NCT07310433. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients
ClinicalTrials.gov study NCT03987217. IPD Sharing: NO. Countries: 1. Publications: 0.
Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
ClinicalTrials.gov study NCT01240629. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT07218809. IPD Sharing: YES. Countries: 21. Publications: 0.
A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT00516841. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT00003449. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT04631601. IPD Sharing: YES. Countries: 6. Publications: 0.
A Clinical Trial to Investigate the Clinical Drug-Drug Interaction of Divarasib With Probe Substrates of P-Glycoprotein and Breast Cancer Resistance Protein in Healthy Participants
ClinicalTrials.gov study NCT06677957. IPD Sharing: NO. Countries: 1. Publications: 0.
Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT05445609. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT07213674. IPD Sharing: YES. Countries: 17. Publications: 0.
Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare Population
ClinicalTrials.gov study NCT02518698. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT01083615. IPD Sharing: Not stated. Countries: 5. Publications: 0.
A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in Patients With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT07311694. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Hypopressive Exercise Associated With Strength and Resistance Training in Women Treated for Gynecological Cancer
ClinicalTrials.gov study NCT05493319. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy Study of CPC634 (CriPec® Docetaxel) in Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT03742713. IPD Sharing: NO. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.